Back to News
Market Impact: 0.3
Generic drugmaker Sandoz lowers sales outlook, lifts profit forecast
Source: reuters.com
Corporate Guidance & OutlookHealthcare & BiotechCompany Fundamentals
Sandoz lowered its full-year sales growth guidance while raising its core earnings margin forecast. The article fragment says short-term biosimilar-supply constraints weighed on performance but provides no revised figures or further details.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
mixed
Sentiment Score
-0.15
Ticker Sentiment
SDZ-0.35
More News
- What investors need to know about Alphabet's stock-busting earnings report
- Our next steps for Alphabet stock after earnings disappoint at nearly every turn
- SK Hynix says the memory-chip shortage will last until 2030—and more than half its production is booked for the next two years
- China’s tech darlings are losing their shine. Here’s what’s behind the sell-off
- GE Vernova shares slip despite a beat-and-raise. What the sellers are getting wrong
- Microsoft’s strong quarter backs up its stock rebound. Here's our new price target